Bliss Healthcare Services-Research ( Site 0030)

Orlando, Florida 32806

0 studies enrolling now · 1 studies all time

What they study most

HIV-1 Infection

Studies at this site

• Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033) — Running, not enrolling